Cardiovascular Systems, Inc./ US1416191062 /
| 12/10/2019 9:59:39 PM | Chg. -0.78 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 43.63USD | -1.75% | 9,168 Turnover: 401,415.80 |
-Bid Size: - | -Ask Size: - | 44.48 | 43.43 |
GlobeNewswire
12/10
Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
GlobeNewswire
12/10
Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) ...
GlobeNewswire
12/10
Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank
Newsfile Corp
12/10
YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Antagonists fr...
GlobeNewswire
12/6
Applied Therapeutics Announces Presentation of Pre-Clinical Data Highlighting AT-001 for Treatment o...
GlobeNewswire
12/5
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI F...
GlobeNewswire
12/5
Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Piv...
GlobeNewswire
12/4
CITIZEN CPR FOUNDATION BRINGS THE ENTIRE CHAIN OF SUDDEN CARDIAC ARREST SURVIVAL TO SEATTLE, WA
Newsfile Corp
12/4
Neovasc Named Finalist in Questex's Fierce Innovation Awards Lifesciences Edition 2019
GlobeNewswire
12/4
Neovasc Named Finalist in Questex’s Fierce Innovation Awards LifeSciences Edition 2019
GlobeNewswire
12/2
Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
GlobeNewswire
12/2
European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosap...
